Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 9

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 9
---
 Common Stock to be issued to Enfusion Securityholders (as defined below)
pursuant to the Transactions. This Proxy Statement/Prospectus also constitutes a proxy statement for Enfusion under the Securities Exchange Act of 1934, as amended (the “”), and a notice of meeting with respect to the
Special Meeting of Enfusion Stockholders.

You should rely only on the information contained in or incorporated by reference into this
Proxy Statement/Prospectus. No one has been authorized to provide you with information that is different from that contained in, or incorporated by reference into, this Proxy Statement/Prospectus. This Proxy Statement/Prospectus is dated March 20,
2025, and you should assume that the information contained in this Proxy Statement/Prospectus is accurate only as of such date. You should also assume that the information incorporated by reference into this Proxy Statement/Prospectus is accurate
only as of the date of such information.

This Proxy Statement/Prospectus does not constitute an offer to sell, or a solicitation of an offer to buy, any securities, or the solicitation of a proxy in any jurisdiction to or from any person to whom it is unlawful to make any such offer or solicitation in such jurisdiction. Information contained in this Proxy Statement/Prospectus regarding Clearwater has been provided by Clearwater, and information contained in this Proxy Statement/Prospectus regarding Enfusion has been provided by Enfusion.

iv

TABLE OF CONTENTS

|                                                                                  |     | Page |     |
| QUESTIONS AND ANSWERS                                                            |     |      |   1 |
| SUMMARY                                                                          |     |      |  13 |
| MARKET PRICE AND DIVIDEND INFORMATION                                            |     |      |  28 |
| CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS                        |     |      |  29 |
| RISK FACTORS                                                                     |     |      |  31 |
| Risks Relating to the Transactions                                               |     |      |  31 |
| Risks Relating to Clearwater Following Completion of the                         
 Transactions                                                                     |     |      |  36 |
| Risks Relating to Tax Matters                                                    |     |      |  41 |
| Other Risks of Clearwater and Enfusion                                           |     |      |  41 |
| INFORMATION ABOUT ENFUSION                                                       |     |      |  43 |
| INFORMATION ABOUT CLEARWATER                                                     |     |      |  44 |